DRUG TRANSPORT IN THE BRAIN - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 455

268. Waclawski AP, Sinko PJ. 1996. Oral absorption of anti-acquired immune deficiency
syndrome nucleoside analogues: 2. Carrier-mediated intestinal transport of stavudine in
rat and rabbit preparations. J Pharm Sci 85:478-485.
269. Terasaki T, Pardrigde WM. 1988. Restricted transport pf 3 -azido-3 -deoxythymidine
and dideoxynucleosides through the blood-brain barrier. J Infect Dis 158:630-632.
270. Baldwin SA, Beal PR, King AE, Yao SYM, Young JD, Cass CE. 2004. The equilibrative
nucleoside transporter family, SLC29. Pflugers Arch Eur J Physiol 447:735-743.
271. Podgorska M, Kocbuch K, Pawelczyk T. 2005. Recent advances in studies on biochemical
and structural properties of equilibrative and concentrative nucleoside transporters. Acta
Biochim Pol 52:749-758.
272. Hyde RJ, Cass CE, Young JD, Baldwin SA. 2001. The ENT family of eukaryote nucleoside
and nucleobase transporters: Recent advances in the investigation of structure/function
relationships and the identification of novel isoforms. Mol Membr Biol 18:53-63.
273. Sundaram M, Yao SYM, Young JD, Cass CE, Ingram JC, Berry ZA, Abidi F, Baldwin SA.
2001. Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive
nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and
anti-cancer drugs. J Biol Chem 276:45270-45275.
274. Mani RS, Marjan JMJ, Graham KA, Cass CE, Young JD, Hammond JR, Baldwin SA.
1998. Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2)
in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional
reconstitution in proteoliposomes. J Biol Chem 273:30818-30825.
275. Jennings LL, Hao C, Cabrita MA, Vickers MF, Baldwin SA, Young JD, Cass CE. 2001.
Distinct regional distribution of human equilibrative nucleoside transporter proteins 1
and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology 40:722-
731.
276. Anderson CM, Xiong W, Geiger JD, Parkinson FE, Young JD, Cass CE, Baldwin
SA. 1999. Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside
transporters (ENT1) in brain. J Neurochem 73:867-873.
277. Pastor-Anglada M, Felipe A, Javier Casado F. 1998. Transport and mode of action of
nucleoside derivatives used in chemical and antiviral therapies. Trends Pharmacol Sci
19:424-430.
278. Crawford CR, Patel DH, Belt JA, Naeve C. 1998. Cloning of the human equilibrative,
nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei
by functional expression in a transport-deficient cell line. J Biol Chem 273:5288-
5293.
279. Sinclair CJD, LaRiviere CG, Young JD, Cass CE, Baldwin SA, Parkinson FE. 2000.
Purine uptake and release in rat C6 glioma cells: nucleoside transport and purine
metabolism under ATP-depleting conditions. J Neurochem 75:1528-1538.
280. Yao SYM, Ng AML, Sundaram M, Cass CE, Baldwin SA, Young JD. 2001. Transport
of antiviral 3 -deoxy-nucleoside drugs by recombinant human and rat equilibrative,
nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins
produced in Xenopus oocytes. Mol Membr Biol 18:161-167.
281. Baldwin SA, Hyde RJ, Foppolo S, Barnes K, Yao SYM, Ng AML, Ritzel MWL, Young
JD, Cass CE. 2005. Functional characterization of novel human and mouse equilibrative
nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol
Chem 280:15880-15887.